GNC Hit With Suit Claiming Diet Pills Led To Liver Damage

Law360, New York (January 28, 2014, 4:20 PM EST) -- GNC Holdings Inc. was hit Monday with a putative class action in New Jersey federal court, the latest lawsuit to arise from its sale of a since-recalled diet supplement, made by a Texas company, that has been linked to liver damage.

The putative class action was launched against GNC as well as the product's manufacturer, Dallas-based USPLabs LLC, and claims GNC sold USPLabs' OxyElite Pro line of products while both companies were well aware of widespread reports that the products were causing severe liver damage. The OxyElite Pro line was voluntarily recalled in November 2013 following a warning letter to the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Subscribers Only

Nature of Suit

Subscribers Only

Judge

Subscribers Only

Date Filed

Subscribers Only

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!